Stelis' pact with the Russian Direct Investment Fund (RDIF) follows similar deals struck by Indian pharmaceutical firms Gland Pharma and Hetero to make millions of doses of the vaccine, which has proven to be 91.6% effective against COVID-19.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3cTDioW
via IFTTT
0 comments:
Post a Comment